You are here

  • Home
  • Archive
  • Volume 101, Issue Suppl 1
  • G95 The Drooling Reduction Intervention (DRI) trial: Is hyoscine or glycopyrronium more effective and acceptable for the treatment of drooling in children with neurodisability?

Citation Tools

Article menu
Download PDFPDF
British Paediatric Neurology Association and British Academy of Childhood Disability
G95 The Drooling Reduction Intervention (DRI) trial: Is hyoscine or glycopyrronium more effective and acceptable for the treatment of drooling in children with neurodisability?

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Parr J, Todhunter E, Pennington L, et al
G95 The Drooling Reduction Intervention (DRI) trial: Is hyoscine or glycopyrronium more effective and acceptable for the treatment of drooling in children with neurodisability?
Archives of Disease in Childhood 2016;101:A55-A56.